IP Library Granted Patent US 11,746,367
Granted Patent B2
US 11,746,367 · App. 15/566,904 · Granted Sep 5, 2023

Barcoding systems and methods for gene sequencing and other applications

Inventors: David A. Weitz (Bolton, MA); Huidan Zhang (Cambridge, MA); John Heyman (Somerville, MA); Allon Moshe Klein (Boston, MA)
Assignee: President and Fellows of Harvard College
C12P19/34C12N15/1006C12N15/1065C12N15/1093C12Q1/6869C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,746,367
App. No.
15/566,904
Granted
Sep 5, 2023
Kind
B2
Abstract

The present invention generally relates to microfluidics and labeled nucleic acids. In one aspect, the present invention is generally directed to a method, wherein the method includes providing a plurality of droplets comprising particles, the particles comprising oligonucleotides, and attaching a nucleic acid sequence to the oligonucleotides. Certain embodiments are generally directed to systems and methods for splitting a droplet into two or more droplets. Certain embodiments are generally directed to systems and methods for sorting fluidic droplets in a liquid.

Claims (25)

1. A method, comprising:

providing a plurality of droplets comprising particles such that at least about 90% of the droplets contains one particle or no particle, the particles comprising oligonucleotides, the oligonucleotides comprising an adapter sequence that is identical for all of the plurality of droplets and particles, and a barcode sequence comprising first barcode selected from a pre-defined pool of first barcodes and a second barcode selected from a pre-defined pool of second barcodes, such that substantially each of the particles comprises distinguishable barcode sequences, wherein the barcode sequences of the pre-defined pool of first barcodes and the barcode sequences of the pre-defined pool of second barcodes are separated by a specific distance; and

attaching nucleic acid sequences to the oligonucleotides, wherein at least some of the nucleic acid sequences comprise a recognition sequence that is at least 80% complementary to a nucleic acid present within the droplet containing the respective nucleic acid sequence, wherein attaching a nucleic acid sequence to the oligonucleotides comprises exposing the adapter sequence to a sequence comprising (1) a sequence complementary to the adapter sequence, and (2) two or more primers, wherein the two or more primers comprise a gene-specific inner forward primer comprising the sequence complementary to the adapter sequence and a sequence complementary to the nucleic acid sequence, and a gene-specific reverse primer, and wherein the concentration of the gene-specific inner forward primer is lower than the concentration of the gene-specific reverse primer;

exposing the two or more primers to a nucleic acid sequence comprising a target of the two or more primers; and

applying amplification using the two or more primers to produce an oligonucleotide comprising the first barcode, the second barcode, and the nucleic acid sequence, wherein a gene-specific amplicon is generated using the gene-specific inner forward primer and the gene-specific reverse primer, and wherein the amplicon is further amplified using the oligonucleotide and the gene-specific reverse primer.

2. The method of claim 1 , wherein the pre-defined pool of first barcodes comprises at least about 300 distinguishable barcodes.

3. The method of claim 1 , wherein the pre-defined pool of second barcodes comprises at least about 300 distinguishable barcodes.

4. The method of claim 1 , wherein the nucleic acid sequence is configured to bind to genomic DNA.

5. The method of claim 1 , wherein at least some of the oligonucleotides are attached to the surface of the particles.

6. The method of claim 1 , wherein at least some of the oligonucleotides comprise a cleavable linker.

7. The method of claim 6 , wherein the cleavable linker is a photocleavable linker.

8. The method of claim 6 , wherein the cleavable linker is a chemically cleavable linker.

9. The method of claim 6 , wherein the cleavable linker is an enzymatically cleavable linker.

10. The method of claim 1 , further comprising releasing at least some of the oligonucleotides from the particles.

11. The method of claim 1 , further comprising exposing the nucleic acid sequence attached to the oligonucleotides to nucleic acids arising from a plurality of cells which are present in at least some of the plurality of droplets.

12. The method of claim 11 , wherein the plurality of cells is present in the plurality of droplets at no more than 1 cell/droplet.

13. The method of claim 11 , further comprising lysing at least some of the cells within the droplets.

14. The method of claim 1 , wherein the adapter sequence comprises no more than 10 nucleotides.

15. The method of claim 1 , wherein the adapter sequence comprises at least 5 nucleotides.

16. A method, comprising:

providing a plurality of at least 10,000 microfluidic droplets containing cells, at least about 90% of the plurality of droplets containing one cell or no cell;

lysing the cells within the plurality of microfluidic droplets to release nucleic acid from the cells;

attaching oligonucleotides to the nucleic acids within the droplets, wherein an oligonucleotide comprises an adapter sequence that is identical for all of the plurality of droplets and particles, and a barcode sequence comprising a first barcode selected from a pre-defined pool of first barcodes, a second barcode selected from a pre-defined pool of second barcodes, by exposing the adapter sequence to a sequence comprising (1) a sequence complementary to the adapter sequence, and (2) two or more primers, wherein the two or more primers comprise a gene-specific inner forward primer comprising the sequence complementary to the adapter sequence and a sequence complementary to the nucleic acid, and a gene-specific reverse primer, and wherein the concentration of the gene-specific inner forward primer is lower than the concentration of the gene-specific reverse primer;

exposing the two or more primers to a nucleic acid sequence comprising a target of the two or more primers, and

applying amplification to produce amplified oligonucleotides comprising the first barcode, the second barcode, and the nucleic acid sequence, wherein a gene-specific amplicon is generated using the gene-specific inner forward primer and the gene-specific reverse primer, and wherein the amplicon is further amplified using the oligonucleotide and the gene-specific reverse primer, thereby producing selectively amplified nucleic acids within the droplets bound to oligonucleotides, wherein for at least about 90% of the droplets, the oligonucleotide within the droplet is distinguishable from oligonucleotides within other droplets of the plurality of droplets.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2018
From: HEYMAN, JOHN A.; KLEIN, ALLON M.; WEITZ, DAVID A.; ZHANG, HUIDAN
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 047762/0632 →
CONFIRMATORY LICENSE Recorded Jul 5, 2018
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046498/0988 →
Continuity (2)
Provisional Application 62149361 · Apr 17, 2015
Related Publication 20180087078A1 · Mar 29, 2018
Cited By (5)
US 12,331,287 US 12,416,033 US 12,545,953 US 12,551,860 US 12,709,767